Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 864
Guide Official Revision Description Reason for Update
Version Date Number Of Change
2021 02/24/2021 7. Medical Policy In Reference Materials for
Obstructive Apnea,
Frequently Asked Questions,
added information on the
four types of sleep studies.
2021 02/24/2021 8. Administrative Added Conditions AMEs Can
Issue (CACI) and Special
Issuance (SI) to the
Glossary/Acronyms.
2021 01/27/2021 1. Medical Policy In Specifications for
Psychiatric and
Psychological Evaluations,
added link for information on
Selecting MMPI-2 vs MMPI-
3.
2021 01/27/2021 2. Medical Policy In Pharmaceuticals, Do Not
Issue/ Do Not Fly, Diabetic
Medications, removed
prohibitions on SGLT2
inhibitors. Added
pramlintide (Symlin) as not
allowed.
2021 01/27/2021 3. Medical Policy In Disease Protocols,
Diabetes Mellitus Type II -
Medication Controlled,
revised and reformatted
Acceptable Combinations of
Diabetes Medication
guidance and chart to
include SGLT2 inhibitors.
2021 01/27/2021 4. Medical Policy In Substances of
Dependence/Abuse (Drugs
and Alcohol), General
Information for All AMEs,
reorganized guidance with
new Drug and Alcohol Event
– FAA Certification Aid –
Required Information.
2021 01/27/2021 5. Medical Policy In Substances of
Dependence/Abuse (Drugs
and Alcohol), Drug/Alcohol
Monitoring Programs and
HIMS section, added
guidance for HIMS AME –
Huddle Electronic Case
Submission and FAQs.
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
